APP vs EW · P/E 61, rev $5.48B vs P/E 47, rev $1.39B
Applovin Corp (APP) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Applovin Corp (APP) is a advertising agencies company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported APP revenue for 2025-12-31 was $5.48B. Net income was $3.33B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. APP currently screens at market cap $113.70B and trailing P/E 61.0.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
APP currently screens at market cap $113.70B and trailing P/E 61.0. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the APP and EW stock pages for the full models.
Not investment advice.